Ajanta Pharma Limited | AJANTPHARM | NSE - Pharmaceuticals


Performance Valuation Growth Insiders Summary Balance Sheet Income Statement Cash Flow Quarterly
INR in Million. Fiscal year ends in March. Figures are consolidated and restated..

Upgrade Membership to see 10 year accurate financial statements.
 Chart
2017
2018
2019
2020
2021
Revenue
Revenue
20,01621,30920,55425,87929,157
Cost of revenue
Cost of revenue
-4,146-4,064-3,835-6,557-6,451
Gross Profit
Gross Profit
15,871
17,245
16,719
19,322
22,706
Sales, general & ad...
Sales, general and administrative
-8,980-10,661-11,055-12,488-12,461
Depreciation
Depreciation and amortization
-612-596-721-957-1,161
Provision
Provision
00000
Other op inc/exp...
Other operating income/expenses
00000
Operating income
Operating income EBIT
6,278
5,988
4,944
5,876
9,085
 
      
Profit before tax
Profit before tax
6,4586,2265,1436,6409,002
Net Income
Net income
5,068
4,686
3,870
4,677
6,539
 
 
 
 
 
 
 
EPS Basic
EPS Basic in Rupees
57.59
53.25
43.97
53.60
75.09